Results 181 to 190 of about 24,350 (247)

FLI1 Expression in Invasive Breast Carcinoma: Clinicopathological Correlations and Prognostic Implications. [PDF]

Genes (Basel)
Doly NJ, Lee DY, Tahsin KN, Akhter J, Sultana S, Khatun J, Chua SZ, Banu AT, Chen Q, Iqbal J.   +9 more
europepmc   +1 more source

Table S2 from FBXO24 Suppresses Breast Cancer Tumorigenesis by Targeting LSD1 for Ubiquitination

, 2023
Bo Dong, Xiang Song, Xinzhao Wang, Tao Dai, Jianlin Wang, Zhiyong Yu, Jiong Deng, B. Mark Evers, Yadi Wu   +8 more
openalex   +1 more source

Regulation of <i>INSM1</i> Gene Expression and Neuroendocrine Differentiation in High-Risk Neuroblastoma. [PDF]

Biology (Basel)
Chen C, Cheng S, Yu X, Lee Y, Lan MS.
europepmc   +1 more source

Correction: Decreased Expression of CoREST1 and CoREST2 Together with LSD1 and HDAC1/2 during Neuronal Differentiation

, 2015
The PLOS ONE Staff
openalex   +2 more sources

RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition

, 2022
Wanting Han, Mingyu Liu, Dong Han, Muqing Li, Anthia A. Toure, Zifeng Wang, Anna Besschetnova, Susan Patalano, Jill A. Macoska, Shuai Gao, Housheng Hansen He, Changmeng Cai   +11 more
openalex   +2 more sources

Experimental Validation of Genome-Environment Associations in Arabidopsis. [PDF]

Mol Ecol
Luo Y, Lorts CM, Lawrence-Paul EH, Lasky JR.   +3 more
europepmc   +1 more source

Synthesis, structure-activity relationship studies and biological characterization of new [1,2,4]triazolo[1,5-a]pyrimidine-based LSD1/KDM1A inhibitors

, 2019
Shuai Wang, Zhong‐Rui Li, Feng‐Zhi Suo, Xiaohan Yuan, Bin Yu, Hong‐Min Liu   +5 more
openalex   +1 more source

Discovery of tranylcypromine analogs with an acylhydrazone substituent as LSD1 inactivators: Design, synthesis and their biological evaluation

, 2017
Kai Sun, Jiadi Peng, Feng‐Zhi Suo, Ting Zhang, Yun-Dong Fu, Yi‐Chao Zheng, Hong‐Min Liu   +6 more
openalex   +1 more source

Supplementary Figure S6 from LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1

, 2023
Ming Sun, Fengqi Nie, Yunfei Wang, Zhihong Zhang, Jiakai Hou, Dandan He, Min Xie, Lin Xu, Wei De, Zhaoxia Wang, Jun Wang   +10 more
openalex   +1 more source

Identification of epigenetic monotherapy candidates in taxane-resistant CRPC. [PDF]

Turk J Biol
Cevatemre B, Bulut İ, Karyemez E, Açilan C.   +3 more
europepmc   +1 more source